Tradestie Institutional Equity Comparison Engine

AURA vs VIR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VIR Overall Edge

VIR Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vir Biotechnology, Inc. Common Stock (VIR) driven by superior Valuation, Momentum & Technical while AURA counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, AURA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VIR at 4.3x Forward P/E and -70.2% operating margin (+19582.5% YoY). In options structure, AURA sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro) against VIR sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VIR
AURA N/M vs VIR 4.3x Fwd P/E
Growth & Margin Winner AURA
Op Margin 0.0% vs -70.2% ยท YoY +0.0% vs +19582.5%
Momentum & Technical Winner VIR
1Y +30.4% vs +78.4% ยท 52W Pos 52% vs 49%
Options & Structure Winner AURA
CONSOLIDATION (22nd %ile IV) vs BREAKDOWN (6th %ile IV)
AURA NASDAQ
Aura Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$7.21
+1.41% 1D
Market Cap $728.6M
1M Return +18.2%
1Y Return +30.38%
Forward P/E N/M
Unified AI Score
31.1 / 100 SELL
Tech 8.0 Fund 39.0 Flow 71.0 Mom 44.0
VIR NASDAQ
Vir Biotechnology, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$9.76
-2.01% 1D
Market Cap $2.1B
1M Return -2.01%
1Y Return +78.43%
Forward P/E 4.3x
Unified AI Score
41.0 / 100 SELL
Tech 26.0 Fund 46.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AURA +30.38% VIR +78.43% Spread: +48.05 pp (VIR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AURA TTM Op. Margin: 0.0% VIR TTM Op. Margin: -70.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AURA vs VIR. Trailing 12-month operating profitability (AURA 0.0% vs VIR -70.2%) and valuation multiples (AURA N/M vs VIR 4.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AURA (4) vs VIR (6)
Institutional Metric AURA VIR Criterion Row Winner
Market Capitalization Scale $728.6M $2.1B Larger Scale VIR
Trailing P/E Ratio Valuation N/M 4.3x Lower Multiple VIR
Forward P/E Ratio Valuation N/M 4.3x Lower Multiple VIR
Revenue Growth (YoY) Growth +0.0% +19582.5% Higher Growth VIR
Operating Margin (TTM) Profitability 0.0% -70.2% Higher Margin AURA
Net Profit Margin Profitability 0.0% -61.0% Higher Margin AURA
Return on Equity (ROE) Capital Efficiency -61.7% -21.8% Higher ROE VIR
52-Week Range Position Momentum 52% ($5โ€“$10) 49% ($5โ€“$14) Stronger Trend AURA
Beta / 30D Volatility Risk Regime 0.92ฮฒ ยท 75% Vol 1.71ฮฒ ยท 102% Vol Lower Realized Risk AURA
Unified Institutional Score Composite Signal 31.1 / 100 (SELL) 41.0 / 100 (SELL) Higher Composite VIR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AURA vs VIR Buy Guide
AURA CONSOLIDATION
135d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live AURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VIR BREAKDOWN
5d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live VIR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AURA nor VIR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.